Sign Up to like & get
recommendations!
1
Published in 2022 at "Clinical and Experimental Pharmacology and Physiology"
DOI: 10.1111/1440-1681.13675
Abstract: Thyrotropin‐releasing hormone (TRH) and the TRH mimetic taltirelin have been used in Japan for the treatment of spinocerebellar degeneration (SCD), a type of progressive ataxia. A TRH mimetic, rovatirelin, ameliorates ataxia symptoms in the rolling…
read more here.
Keywords:
rovatirelin ameliorates;
motor dysfunction;
motor;
model ... See more keywords